{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:24:35Z","timestamp":1780673075443,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12933-017-0619-2","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T08:50:09Z","timestamp":1507625409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Glycated albumin and its variability as an indicator of cardiovascular autonomic neuropathy development in type 2 diabetic patients"],"prefix":"10.1186","volume":"16","author":[{"given":"Ji Eun","family":"Jun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Bin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yeon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyuri","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Man","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Yeon","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon-Kyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,10]]},"reference":[{"issue":"10","key":"619_CR1","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","volume":"100","author":"SM Grundy","year":"1999","unstructured":"Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100(10):1134\u201346.","journal-title":"Circulation"},{"issue":"2","key":"619_CR2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/dc09-1294","volume":"33","author":"R Pop-Busui","year":"2010","unstructured":"Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care. 2010;33(2):434\u201341.","journal-title":"Diabetes Care"},{"issue":"5","key":"619_CR3","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2337\/db08-0063","volume":"57","author":"A Ceriello","year":"2008","unstructured":"Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57(5):1349\u201354.","journal-title":"Diabetes"},{"issue":"2","key":"619_CR4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.6065\/apem.2015.20.2.74","volume":"20","author":"JE Lee","year":"2015","unstructured":"Lee JE. Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol. Ann Pediatr Endocrinol Metab. 2015;20(2):74\u20138.","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"619_CR5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cca.2014.03.001","volume":"433","author":"M Koga","year":"2014","unstructured":"Koga M. Glycated albumin; clinical usefulness. Clin Chimica Acta Int J Clin Chem. 2014;433:96\u2013104.","journal-title":"Clin Chimica Acta Int J Clin Chem"},{"issue":"3","key":"619_CR6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jdiacomp.2012.12.001","volume":"27","author":"M Koga","year":"2013","unstructured":"Koga M, Murai J, Morita S, Saito H, Kasayama S. Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus. J Diabetes Complicat. 2013;27(3):211\u20133.","journal-title":"J Diabetes Complicat"},{"issue":"22","key":"619_CR7","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1001\/jama.2010.785","volume":"303","author":"IB Hirsch","year":"2010","unstructured":"Hirsch IB, Brownlee M. Beyond hemoglobin A1c\u2013need for additional markers of risk for diabetic microvascular complications. JAMA. 2010;303(22):2291\u20132.","journal-title":"JAMA"},{"issue":"6","key":"619_CR8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jdiacomp.2014.06.015","volume":"28","author":"J Pan","year":"2014","unstructured":"Pan J, Li Q, Zhang L, Jia L, Tang J, Bao Y, Jia W. Serum glycated albumin predicts the progression of diabetic retinopathy\u2014a five year retrospective longitudinal study. J Diabetes Complicat. 2014;28(6):772\u20138.","journal-title":"J Diabetes Complicat"},{"issue":"4","key":"619_CR9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S2213-8587(13)70199-2","volume":"2","author":"E Selvin","year":"2014","unstructured":"Selvin E, Rawlings AM, Grams M, Klein R, Sharrett AR, Steffes M, Coresh J. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol. 2014;2(4):279\u201388.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"619_CR10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00592-016-0900-y","volume":"53","author":"N Wang","year":"2016","unstructured":"Wang N, Guo C, Han P, Li T. Glycated albumin indicates peripheral diabetic neuropathy. Acta Diabetol. 2016;53(6):973\u20139.","journal-title":"Acta Diabetol"},{"issue":"7","key":"619_CR11","first-page":"1067","volume":"71","author":"LJ Pu","year":"2007","unstructured":"Pu LJ, Lu L, Shen WF, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Ding FH, Chen QJ, et al. Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients. Circ J Off J Japn Circ Soc. 2007;71(7):1067\u201373.","journal-title":"Circ J Off J Japn Circ Soc"},{"issue":"6","key":"619_CR12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jdi.12085","volume":"4","author":"Y Sato","year":"2013","unstructured":"Sato Y, Nagao M, Asai A, Nakajima Y, Takaya M, Takeichi N, Takemitsu S, Sudo M, Kano-Wakakuri T, Ishizaki A, et al. Association of glycated albumin with the presence of carotid plaque in patients with type 2 diabetes. J Diabetes Investig. 2013;4(6):634\u20139.","journal-title":"J Diabetes Investig"},{"key":"619_CR13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12933-015-0233-0","volume":"14","author":"JE Jun","year":"2015","unstructured":"Jun JE, Jin SM, Baek J, Oh S, Hur KY, Lee MS, Lee MK, Kim JH. The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes. Cardiovasc Diabetol. 2015;14:70.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"619_CR14","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2337\/dc12-2264","volume":"36","author":"G Penno","year":"2013","unstructured":"Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, Morano S, Cavalot F, Lamacchia O, Laviola L, et al. HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular Events (RIACE) Italian multicenter study. Diabetes Care. 2013;36(8):2301\u201310.","journal-title":"Diabetes Care"},{"issue":"3","key":"619_CR15","doi-asserted-by":"crossref","first-page":"e91137","DOI":"10.1371\/journal.pone.0091137","volume":"9","author":"JM Hermann","year":"2014","unstructured":"Hermann JM, Hammes HP, Rami-Merhar B, Rosenbauer J, Schutt M, Siegel E, Holl RW. HbA1c variability as an independent risk factor for diabetic retinopathy in type 1 diabetes: a German\/Austrian multicenter analysis on 35,891 patients. PLoS ONE. 2014;9(3):e91137.","journal-title":"PLoS ONE"},{"issue":"11","key":"619_CR16","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2337\/dc08-0864","volume":"31","author":"ES Kilpatrick","year":"2008","unstructured":"Kilpatrick ES, Rigby AS, Atkin SL. A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care. 2008;31(11):2198\u2013202.","journal-title":"Diabetes Care"},{"issue":"6","key":"619_CR17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/erc.12.53","volume":"10","author":"G Karayannis","year":"2012","unstructured":"Karayannis G, Giamouzis G, Cokkinos DV, Skoularigis J, Triposkiadis F. Diabetic cardiovascular autonomic neuropathy: clinical implications. Exp Rev Cardiovasc Ther. 2012;10(6):747\u201365.","journal-title":"Exp Rev Cardiovasc Ther"},{"issue":"1","key":"619_CR18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4239\/wjd.v5.i1.17","volume":"5","author":"G Dimitropoulos","year":"2014","unstructured":"Dimitropoulos G, Tahrani AA, Stevens MJ. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes. 2014;5(1):17\u201339.","journal-title":"World J Diabetes"},{"issue":"1","key":"619_CR19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4239\/wjd.v6.i1.80","volume":"6","author":"AS Balcioglu","year":"2015","unstructured":"Balcioglu AS, Muderrisoglu H. Diabetes and cardiac autonomic neuropathy: clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes. 2015;6(1):80\u201391.","journal-title":"World J Diabetes"},{"issue":"7","key":"619_CR20","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/dmrr.1239","volume":"27","author":"V Spallone","year":"2011","unstructured":"Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, Stevens M, Kempler P, Hilsted J, Tesfaye S, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011;27(7):639\u201353.","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"619_CR21","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1590\/S0066-782X2008000400014","volume":"90","author":"LC Rolim","year":"2008","unstructured":"Rolim LC, Sa JR, Chacra AR, Dib SA. Diabetic cardiovascular autonomic neuropathy: risk factors, clinical impact and early diagnosis. Arq Bras Cardiol. 2008;90(4):e24\u201331.","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"619_CR22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1464-5491.1999.00001.x","volume":"16","author":"A Gottsater","year":"1999","unstructured":"Gottsater A, Ahmed M, Fernlund P, Sundkvist G. Autonomic neuropathy in Type 2 diabetic patients is associated with hyperinsulinaemia and hypertriglyceridaemia. Diabetic Med J Br Diabet Assoc. 1999;16(1):49\u201354.","journal-title":"Diabetic Med J Br Diabet Assoc"},{"issue":"3","key":"619_CR23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2337\/diab.45.3.308","volume":"45","author":"JP Toyry","year":"1996","unstructured":"Toyry JP, Niskanen LK, Mantysaari MJ, Lansimies EA, Uusitupa MI. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis. Diabetes. 1996;45(3):308\u201315.","journal-title":"Diabetes"},{"issue":"16","key":"619_CR24","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.jacc.2014.06.1201","volume":"64","author":"HR Middlekauff","year":"2014","unstructured":"Middlekauff HR, Park J, Moheimani RS. Adverse effects of cigarette and noncigarette smoke exposure on the autonomic nervous system: mechanisms and implications for cardiovascular risk. J Am Coll Cardiol. 2014;64(16):1740\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"619_CR25","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1089\/dia.2012.0031","volume":"14","author":"JK Snell-Bergeon","year":"2012","unstructured":"Snell-Bergeon JK, Wadwa RP. Hypoglycemia, diabetes, and cardiovascular disease. Diabetes Technol Thera. 2012;14(Suppl 1):S51\u20138.","journal-title":"Diabetes Technol Thera"},{"issue":"15","key":"619_CR26","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2009.476","volume":"301","author":"LH Young","year":"2009","unstructured":"Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Heller GV, Iskandrian AE, Wittlin SD, Filipchuk N, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA. 2009;301(15):1547\u201355.","journal-title":"JAMA"},{"issue":"10","key":"619_CR27","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1007\/s00125-006-0368-3","volume":"49","author":"H Marthol","year":"2006","unstructured":"Marthol H, Brown CM, Zikeli U, Ziegler D, Dimitrov N, Baltadzhieva R, Hilz MJ. Altered cerebral regulation in type 2 diabetic patients with cardiac autonomic neuropathy. Diabetologia. 2006;49(10):2481\u20137.","journal-title":"Diabetologia"},{"issue":"7","key":"619_CR28","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0026-0495(03)00095-7","volume":"52","author":"P Valensi","year":"2003","unstructured":"Valensi P, Paries J, Attali JR. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications\u2014the French multicenter study. Metab Clin Exp. 2003;52(7):815\u201320.","journal-title":"Metab Clin Exp"},{"key":"619_CR29","doi-asserted-by":"crossref","first-page":"507216","DOI":"10.1155\/2013\/507216","volume":"2013","author":"A Motataianu","year":"2013","unstructured":"Motataianu A, Balasa R, Voidazan S, Bajko Z. Cardiovascular autonomic neuropathy in context of other complications of type 2 diabetes mellitus. Biomed Res Int. 2013;2013:507216.","journal-title":"Biomed Res Int"},{"issue":"10","key":"619_CR30","doi-asserted-by":"crossref","first-page":"e13463","DOI":"10.1371\/journal.pone.0013463","volume":"5","author":"R Sharma","year":"2010","unstructured":"Sharma R, Buras E, Terashima T, Serrano F, Massaad CA, Hu L, Bitner B, Inoue T, Chan L, Pautler RG. Hyperglycemia induces oxidative stress and impairs axonal transport rates in mice. PLoS ONE. 2010;5(10):e13463.","journal-title":"PLoS ONE"},{"issue":"3","key":"619_CR31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1368-5031.2006.00825.x","volume":"60","author":"E Wright Jr","year":"2006","unstructured":"Wright E Jr, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract. 2006;60(3):308\u201314.","journal-title":"Int J Clin Pract"},{"issue":"8","key":"619_CR32","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2337\/diacare.25.8.1439","volume":"25","author":"A Ceriello","year":"2002","unstructured":"Ceriello A, Quagliaro L, Catone B, Pascon R, Piazzola M, Bais B, Marra G, Tonutti L, Taboga C, Motz E. Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care. 2002;25(8):1439\u201343.","journal-title":"Diabetes Care"},{"issue":"8","key":"619_CR33","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jdiacomp.2016.08.015","volume":"30","author":"A Hayashi","year":"2016","unstructured":"Hayashi A, Takano K, Masaki T, Yoshino S, Ogawa A, Shichiri M. Distinct biomarker roles for HbA1c and glycated albumin in patients with type 2 diabetes on hemodialysis. J Diabetes Complic. 2016;30(8):1494\u20139.","journal-title":"J Diabetes Complic"},{"issue":"2","key":"619_CR34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1507\/endocrj.K09E-234","volume":"57","author":"T Suwa","year":"2010","unstructured":"Suwa T, Ohta A, Matsui T, Koganei R, Kato H, Kawata T, Sada Y, Ishii S, Kondo A, Murakami K, et al. Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM). Endocr J. 2010;57(2):135\u201340.","journal-title":"Endocr J"},{"key":"619_CR35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/2251-6581-13-49","volume":"13","author":"A Arasteh","year":"2014","unstructured":"Arasteh A, Farahi S, Habibi-Rezaei M, Moosavi-Movahedi AA. Glycated albumin: an overview of the in vitro models of an in vivo potential disease marker. J Diabetes Metab Disord. 2014;13:49.","journal-title":"J Diabetes Metab Disord"},{"issue":"7","key":"619_CR36","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/dmrr.1117","volume":"26","author":"BK Rodino-Janeiro","year":"2010","unstructured":"Rodino-Janeiro BK, Gonzalez-Peteiro M, Ucieda-Somoza R, Gonzalez-Juanatey JR, Alvarez E. Glycated albumin, a precursor of advanced glycation end-products, up-regulates NADPH oxidase and enhances oxidative stress in human endothelial cells: molecular correlate of diabetic vasculopathy. Diabetes Metab Res Rev. 2010;26(7):550\u20138.","journal-title":"Diabetes Metab Res Rev"},{"issue":"9","key":"619_CR37","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058\u201370.","journal-title":"Circ Res"},{"issue":"1","key":"619_CR38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/hy1201.097300","volume":"39","author":"Y Hattori","year":"2002","unstructured":"Hattori Y, Suzuki M, Hattori S, Kasai K. Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hypertension. 2002;39(1):22\u20138.","journal-title":"Hypertension."},{"key":"619_CR39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12933-014-0166-z","volume":"14","author":"X Ma","year":"2015","unstructured":"Ma X, Hu X, Zhou J, Hao Y, Luo Y, Lu Z, Bao Y, Jia W. Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c. Cardiovasc Diabetol. 2015;14:16.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"619_CR40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000342055","volume":"123","author":"Y Shen","year":"2012","unstructured":"Shen Y, Pu LJ, Lu L, Zhang Q, Zhang RY, Shen WF. Glycated albumin is superior to hemoglobin A1c for evaluating the presence and severity of coronary artery disease in type 2 diabetic patients. Cardiology. 2012;123(2):84\u201390.","journal-title":"Cardiology"},{"key":"619_CR41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12933-015-0247-7","volume":"14","author":"N Mukai","year":"2015","unstructured":"Mukai N, Ninomiya T, Hata J, Hirakawa Y, Ikeda F, Fukuhara M, Hotta T, Koga M, Nakamura U, Kang D, et al. Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study. Cardiovasc Diabetol. 2015;14:84.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"619_CR42","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.ijcard.2012.05.045","volume":"167","author":"N Furusyo","year":"2013","unstructured":"Furusyo N, Koga T, Ai M, Otokozawa S, Kohzuma T, Ikezaki H, Schaefer EJ, Hayashi J. Plasma glycated albumin level and atherosclerosis: results from the Kyushu and Okinawa Population Study (KOPS). Int J Cardiol. 2013;167(5):2066\u201372.","journal-title":"Int J Cardiol"},{"issue":"4","key":"619_CR43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.115.015415","volume":"132","author":"E Selvin","year":"2015","unstructured":"Selvin E, Rawlings AM, Lutsey PL, Maruthur N, Pankow JS, Steffes M, Coresh J. Fructosamine and glycated albumin and the risk of cardiovascular outcomes and death. Circulation. 2015;132(4):269\u201377.","journal-title":"Circulation"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-017-0619-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T08:16:40Z","timestamp":1570177000000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-017-0619-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,10]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1186\/s12933-017-0619-2","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,10]]},"article-number":"127"}}